Published in Genes Dev on May 01, 1993
Molecular genetics of the RNA polymerase II general transcriptional machinery. Microbiol Mol Biol Rev (1998) 4.49
Intermediates in formation and activity of the RNA polymerase II preinitiation complex: holoenzyme recruitment and a postrecruitment role for the TATA box and TFIIB. Genes Dev (1999) 2.94
The NOT, SPT3, and MOT1 genes functionally interact to regulate transcription at core promoters. Mol Cell Biol (1996) 1.97
Evidence that Spt3 functionally interacts with Mot1, TFIIA, and TATA-binding protein to confer promoter-specific transcriptional control in Saccharomyces cerevisiae. Mol Cell Biol (1997) 1.97
A class of activation domains interacts directly with TFIIA and stimulates TFIIA-TFIID-promoter complex assembly. Mol Cell Biol (1995) 1.85
Quantitative sequential chromatin immunoprecipitation, a method for analyzing co-occupancy of proteins at genomic regions in vivo. Nucleic Acids Res (2004) 1.81
Identification of RTF1, a novel gene important for TATA site selection by TATA box-binding protein in Saccharomyces cerevisiae. Mol Cell Biol (1997) 1.76
Mot1 activates and represses transcription by direct, ATPase-dependent mechanisms. Proc Natl Acad Sci U S A (2002) 1.72
Saccharomyces cerevisiae BUR6 encodes a DRAP1/NC2alpha homolog that has both positive and negative roles in transcription in vivo. Mol Cell Biol (1997) 1.60
Molecular analysis of the SNF2/SWI2 protein family member MOT1, an ATP-driven enzyme that dissociates TATA-binding protein from DNA. Mol Cell Biol (1997) 1.58
The mammalian transcriptional repressor RBP (CBF1) targets TFIID and TFIIA to prevent activated transcription. Genes Dev (1998) 1.47
c-Fos-induced activation of a TATA-box-containing promoter involves direct contact with TATA-box-binding protein. Mol Cell Biol (1994) 1.42
Genetic analysis connects SLX5 and SLX8 to the SUMO pathway in Saccharomyces cerevisiae. Genetics (2005) 1.40
Site-specific cross-linking of TBP in vivo and in vitro reveals a direct functional interaction with the SAGA subunit Spt3. Genes Dev (2008) 1.40
Repression of basal transcription by HMG2 is counteracted by TFIIH-associated factors in an ATP-dependent process. Mol Cell Biol (1994) 1.39
Cloning and biochemical characterization of TAF-172, a human homolog of yeast Mot1. Mol Cell Biol (1998) 1.39
Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression. Mol Cell Biol (1997) 1.37
Analysis of the yeast transcription factor TFIIA: distinct functional regions and a polymerase II-specific role in basal and activated transcription. Mol Cell Biol (1995) 1.35
RNA polymerase II cofactor PC2 facilitates activation of transcription by GAL4-AH in vitro. Mol Cell Biol (1994) 1.34
Mot1 associates with transcriptionally active promoters and inhibits association of NC2 in Saccharomyces cerevisiae. Mol Cell Biol (2002) 1.34
The Dr1/DRAP1 heterodimer is a global repressor of transcription in vivo. Proc Natl Acad Sci U S A (1997) 1.23
MOT1 can activate basal transcription in vitro by regulating the distribution of TATA binding protein between promoter and nonpromoter sites. Mol Cell Biol (1999) 1.23
Functional antagonism between RNA polymerase II holoenzyme and global negative regulator NC2 in vivo. Proc Natl Acad Sci U S A (1997) 1.20
Snf2/Swi2-related ATPase Mot1 drives displacement of TATA-binding protein by gripping DNA. EMBO J (2006) 1.18
Repression of activator-mediated transcription by herpes simplex virus ICP4 via a mechanism involving interactions with the basal transcription factors TATA-binding protein and TFIIB. Mol Cell Biol (1995) 1.17
Human general transcription factor TFIIA: characterization of a cDNA encoding the small subunit and requirement for basal and activated transcription. Proc Natl Acad Sci U S A (1995) 1.16
Transcriptional corepression in vitro: a Mot1p-associated form of TATA-binding protein is required for repression by Leu3p. Mol Cell Biol (1996) 1.14
Testifying the rice bacterial blight resistance gene xa5 by genetic complementation and further analyzing xa5 (Xa5) in comparison with its homolog TFIIAgamma1. Mol Genet Genomics (2006) 1.12
TFIID-specific yeast TAF40 is essential for the majority of RNA polymerase II-mediated transcription in vivo. Genes Dev (1999) 1.10
An RNA aptamer that interferes with the DNA binding of the HSF transcription activator. Nucleic Acids Res (2006) 1.10
Probing TBP interactions in transcription initiation and reinitiation with RNA aptamers that act in distinct modes. Proc Natl Acad Sci U S A (2004) 1.09
A direct interaction between a glutamine-rich activator and the N terminus of TFIIB can mediate transcriptional activation in vivo. Mol Cell Biol (1995) 1.09
Structure and mechanism of the Swi2/Snf2 remodeller Mot1 in complex with its substrate TBP. Nature (2011) 1.09
Identification and analysis of Mot3, a zinc finger protein that binds to the retrotransposon Ty long terminal repeat (delta) in Saccharomyces cerevisiae. Mol Cell Biol (1998) 1.08
Expanding the Mot1 subfamily: 89B helicase encodes a new Drosophila melanogaster SNF2-related protein which binds to multiple sites on polytene chromosomes. Nucleic Acids Res (1996) 1.07
A TATA binding protein regulatory network that governs transcription complex assembly. Genome Biol (2007) 1.07
MOT1-catalyzed TBP-DNA disruption: uncoupling DNA conformational change and role of upstream DNA. EMBO J (2001) 1.06
High-affinity DNA binding by a Mot1p-TBP complex: implications for TAF-independent transcription. EMBO J (2003) 1.05
Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA. Mol Cell Biol (1996) 1.03
The adenovirus E1A repression domain disrupts the interaction between the TATA binding protein and the TATA box in a manner reversible by TFIIB. Mol Cell Biol (1997) 1.02
Architecture of the Saccharomyces cerevisiae SAGA transcription coactivator complex. EMBO J (2014) 1.00
Genome stability roles of SUMO-targeted ubiquitin ligases. DNA Repair (Amst) (2009) 1.00
TAF(II)170 interacts with the concave surface of TATA-binding protein to inhibit its DNA binding activity. Mol Cell Biol (2001) 0.99
Magnesium is required for specific DNA binding of the CREB B-ZIP domain. Nucleic Acids Res (2002) 0.96
Equivalent mutations in the two repeats of yeast TATA-binding protein confer distinct TATA recognition specificities. Mol Cell Biol (1994) 0.96
Activation domain-dependent monoubiquitylation of Gal4 protein is essential for promoter binding in vivo. J Biol Chem (2008) 0.96
TFIIA interacts with TFIID via association with TATA-binding protein and TAF40. Mol Cell Biol (2001) 0.95
Testing for DNA tracking by MOT1, a SNF2/SWI2 protein family member. Mol Cell Biol (1999) 0.94
A proteomics analysis of yeast Mot1p protein-protein associations: insights into mechanism. Mol Cell Proteomics (2008) 0.93
One small step for Mot1; one giant leap for other Swi2/Snf2 enzymes? Biochim Biophys Acta (2011) 0.93
Analysis of TFIIA function In vivo: evidence for a role in TATA-binding protein recruitment and gene-specific activation. Mol Cell Biol (1999) 0.93
Remodeling of regulatory nucleoprotein complexes on the Xenopus hsp70 promoter during meiotic maturation of the Xenopus oocyte. EMBO J (1997) 0.91
TATA-binding protein promotes the selective formation of UV-induced (6-4)-photoproducts and modulates DNA repair in the TATA box. EMBO J (1999) 0.91
Genetic interactions between Nhp6 and Gcn5 with Mot1 and the Ccr4-Not complex that regulate binding of TATA-binding protein in Saccharomyces cerevisiae. Genetics (2005) 0.90
Snf1-dependent and Snf1-independent pathways of constitutive ADH2 expression in Saccharomyces cerevisiae. Genetics (2006) 0.89
Two-step mechanism for modifier of transcription 1 (Mot1) enzyme-catalyzed displacement of TATA-binding protein (TBP) from DNA. J Biol Chem (2012) 0.89
TATA-binding protein variants that bypass the requirement for Mot1 in vivo. J Biol Chem (2008) 0.86
Functional significance of the TATA element major groove in transcription initiation by RNA polymerase II. Nucleic Acids Res (1997) 0.85
Cell cycle-dependent regulation of RNA polymerase II basal transcription activity. Nucleic Acids Res (1995) 0.85
A conserved GA element in TATA-less RNA polymerase II promoters. PLoS One (2011) 0.84
A novel TATA-binding protein-binding protein, ABT1, activates basal transcription and has a yeast homolog that is essential for growth. Mol Cell Biol (2000) 0.83
Mutational analysis of BTAF1-TBP interaction: BTAF1 can rescue DNA-binding defective TBP mutants. Nucleic Acids Res (2005) 0.83
Elucidating the mechanism of DNA-dependent ATP hydrolysis mediated by DNA-dependent ATPase A, a member of the SWI2/SNF2 protein family. Nucleic Acids Res (2009) 0.81
Regulation of anti-sense transcription by Mot1p and NC2 via removal of TATA-binding protein (TBP) from the 3'-end of genes. Nucleic Acids Res (2014) 0.80
Structural and functional analysis of mutations along the crystallographic dimer interface of the yeast TATA binding protein. Mol Cell Biol (2003) 0.80
The carboxyterminus of human c-myb protein stimulates activated transcription in trans. Nucleic Acids Res (1994) 0.78
The gene for human TATA-binding-protein-associated factor (TAFII) 170: structure, promoter and chromosomal localization. Biochem J (2000) 0.78
Structural basis for recognition and remodeling of the TBP:DNA:NC2 complex by Mot1. Elife (2015) 0.77
Molecular Mechanism of Mot1, a TATA-binding Protein (TBP)-DNA Dissociating Enzyme. J Biol Chem (2016) 0.76
The Modifier of Transcription 1 (Mot1) ATPase and Spt16 Histone Chaperone Co-regulate Transcription through Preinitiation Complex Assembly and Nucleosome Organization. J Biol Chem (2016) 0.75
A Transcription Factor IIA Binding Site Differentially Regulates RNA Polymerase II-Mediated Transcription in a Promoter Context-dependent Manner. J Biol Chem (2017) 0.75
Five intermediate complexes in transcription initiation by RNA polymerase II. Cell (1989) 9.22
Crystal structure of a yeast TBP/TATA-box complex. Nature (1993) 7.95
Ageing, fitness and neurocognitive function. Nature (1999) 5.58
An operator at -280 base pairs that is required for repression of araBAD operon promoter: addition of DNA helical turns between the operator and promoter cyclically hinders repression. Proc Natl Acad Sci U S A (1984) 5.42
Each of three "TATA elements" specifies a subset of the transcription initiation sites at the CYC-1 promoter of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1985) 4.69
Function of a yeast TATA element-binding protein in a mammalian transcription system. Nature (1988) 3.91
A transcription reinitiation intermediate that is stabilized by activator. Nature (2000) 3.65
Crystal structure of the yeast TFIIA/TBP/DNA complex. Science (1996) 3.45
Mot1, a global repressor of RNA polymerase II transcription, inhibits TBP binding to DNA by an ATP-dependent mechanism. Genes Dev (1994) 3.45
The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials (2005) 2.98
Intermediates in formation and activity of the RNA polymerase II preinitiation complex: holoenzyme recruitment and a postrecruitment role for the TATA box and TFIIB. Genes Dev (1999) 2.94
A yeast and a human CCAAT-binding protein have heterologous subunits that are functionally interchangeable. Cell (1988) 2.84
Variants of the TATA-binding protein can distinguish subsets of RNA polymerase I, II, and III promoters. Cell (1992) 2.76
Yeast HAP2 and HAP3 activators both bind to the CYC1 upstream activation site, UAS2, in an interdependent manner. Cell (1987) 2.73
The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev (1998) 2.72
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol (2013) 2.70
The role of the TATA-binding protein in the assembly and function of the multisubunit yeast RNA polymerase III transcription factor, TFIIIB. Cell (1992) 2.69
Recruitment of the SWI/SNF chromatin remodeling complex by transcriptional activators. Genes Dev (1999) 2.48
Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol (1994) 2.41
Task coordination and aging: explorations of executive control processes in the task switching paradigm. Acta Psychol (Amst) (1999) 2.22
A yeast TFIIB-related factor involved in RNA polymerase III transcription. Genes Dev (1992) 2.17
The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta (1995) 2.06
Dominant negative mutations in yeast TFIID define a bipartite DNA-binding region. Cell (1991) 1.91
Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis. Diabetologia (2013) 1.88
Upstream repression and CRP stimulation of the Escherichia coli L-arabinose operon. J Mol Biol (1984) 1.84
Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA. Nature (1994) 1.80
Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn (2002) 1.74
Transcription of Escherichia coli ara in vitro. The cyclic AMP receptor protein requirement for PBAD induction that depends on the presence and orientation of the araO2 site. J Mol Biol (1986) 1.67
The region of phage T4 genes 34, 33 and 59: primary structures and organization on the genome. Nucleic Acids Res (1986) 1.66
Molecular analysis of the SNF2/SWI2 protein family member MOT1, an ATP-driven enzyme that dissociates TATA-binding protein from DNA. Mol Cell Biol (1997) 1.58
Severely reduced presence of tissue macrophages in the basal plate of pre-eclamptic placentae. Placenta (2001) 1.58
Influence of attentional capture on oculomotor control. J Exp Psychol Hum Percept Perform (1999) 1.57
Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res (2000) 1.53
[S3-Guidelines "Exocrine pancreatic cancer" 2007]. Z Gastroenterol (2007) 1.52
Isolation of two genes that encode subunits of the yeast transcription factor IIA. Science (1992) 1.49
Preterm birth and the availability of cord blood for HPC transplantation. Transfusion (2000) 1.47
Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay. J Biol Chem (1994) 1.46
Photodynamic therapy in the canine prostate using motexafin lutetium. Clin Cancer Res (2001) 1.43
Yeast nuclear extract contains two major forms of RNA polymerase II mediator complexes. J Biol Chem (2001) 1.42
Model for binding of transcription factor TFIIB to the TBP-DNA complex. Nature (1995) 1.41
The yeast general transcription factor TFIIA is composed of two polypeptide subunits. J Biol Chem (1991) 1.40
Cloning and functional characterization of the gene encoding the TFIIIB90 subunit of RNA polymerase III transcription factor TFIIIB. J Biol Chem (1996) 1.37
Gender, quality of life, and mental disorders in primary care: results from the PRIME-MD 1000 study. Am J Med (1996) 1.37
In vivo regulation of the Escherichia coli araC promoter. J Bacteriol (1983) 1.36
Pancreatic intraepithelial neoplasia revisited and updated. Pancreatology (2008) 1.35
Analysis of the yeast transcription factor TFIIA: distinct functional regions and a polymerase II-specific role in basal and activated transcription. Mol Cell Biol (1995) 1.35
Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells. Br J Cancer (2011) 1.32
Accuracy of radiographer plain radiograph reporting in clinical practice: a meta-analysis. Clin Radiol (2005) 1.31
Architecture of protein and DNA contacts within the TFIIIB-DNA complex. Mol Cell Biol (1998) 1.28
[Medical ethics in the life of a physician of the soul--reflections on the medical ethics concept of Albert Moll (1862-1936)]. Z Gesamte Inn Med (1984) 1.24
Psychiatric comorbidity, health status, and functional impairment associated with alcohol abuse and dependence in primary care patients: findings of the PRIME MD-1000 study. J Consult Clin Psychol (1995) 1.23
Investigation of coronary venous anatomy by retrograde venography in patients with malignant ventricular tachycardia. Circulation (2001) 1.22
Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol (2001) 1.19
Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: structure, expression and involvement in T cell activation. Eur J Immunol (1998) 1.15
The neural correlates of driving. Neuroreport (2001) 1.15
Age differences in the control of looking behavior: do you know where your eyes have been? Psychol Sci (2000) 1.14
Attentional capture and aging: implications for visual search performance and oculomotor control. Psychol Aging (1999) 1.14
Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn (2000) 1.14
The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS (1996) 1.14
Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis. Diabetes Obes Metab (2014) 1.12
Transvenous biventricular defibrillation halves energy requirements in patients. Circulation (2001) 1.12
Ketamine-xylazine anaesthesia blocks consolidation of ocular dominance changes in kitten visual cortex. Nature (1987) 1.12
The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia. Placenta (2008) 1.08
Feto-maternal interactions in pregnancies: placental microparticles activate peripheral blood monocytes. Placenta (2009) 1.07
Reduced osmolarity oral rehydration solution for treating cholera. Cochrane Database Syst Rev (2004) 1.07
Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol (1998) 1.07
Antibiotic treatment for travellers' diarrhoea. Cochrane Database Syst Rev (2000) 1.03
Usefulness of the carina as a radiographic landmark for central venous catheter placement in paediatric patients. Br J Anaesth (2005) 1.02
Psychological implications of infertility in women with polycystic ovary syndrome. Hum Reprod (2008) 1.02
Attentional and oculomotor capture by onset, luminance and color singletons. Vision Res (2000) 1.02
Transcription: basal factors and activation. Curr Opin Genet Dev (1996) 1.01
Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome. Placenta (2005) 1.01
Anticipation in familial pancreatic cancer. Gut (2005) 1.00
Detection of fetal Rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. BJOG (2000) 0.99
Effects of obesity on neuroendocrine, cardiovascular, and immune cell responses to acute psychosocial stress in premenopausal women. Psychoneuroendocrinology (2008) 0.98
TFIIIC determines RNA polymerase III specificity at the TATA-containing yeast U6 promoter. Genes Dev (1995) 0.98
[Basic principles of successful implantation of the SB Charité model LINK intervertebral disk endoprosthesis]. Orthopade (2002) 0.97
Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism. J Assist Reprod Genet (1993) 0.96
Cell-free DNA in urine: a marker for kidney graft rejection, but not for prenatal diagnosis? Ann N Y Acad Sci (2001) 0.95
A comparative study of the effect of three different syncytiotrophoblast micro-particles preparations on endothelial cells. Placenta (2005) 0.95
Rec (formerly Corf) function requires interaction with a complex, folded RNA structure within its responsive element rather than binding to a discrete specific binding site. J Virol (2001) 0.95
Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome. Diabet Med (2008) 0.95
Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children. Cochrane Database Syst Rev (2001) 0.95
Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients. Eur J Nucl Med Mol Imaging (2012) 0.95
Disturbed stress responses in women with polycystic ovary syndrome. Psychoneuroendocrinology (2009) 0.94
Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma. Swiss Med Wkly (2001) 0.93
Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia. Ann N Y Acad Sci (2001) 0.93
Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome. Brain Behav Immun (2007) 0.93
CD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC). III. CD4+ cytotoxic T cells induce apoptosis of APC. Eur J Immunol (1992) 0.93
Radiographers and radiologists reporting plain radiograph requests from accident and emergency and general practice. Clin Radiol (2005) 0.92
Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany. Hum Reprod (2009) 0.92
[Medial hip neck fracture: influence of pre-operative delay on the quality of outcome. Results of data from the external in-hospital quality assurance within the framework of secondary data analysis]. Unfallchirurg (2010) 0.90
Genes controlling spread of breast cancer to lung "gang of 4". Exp Oncol (2008) 0.90
Accuracy of radiographers red dot or triage of accident and emergency radiographs in clinical practice: a systematic review. Clin Radiol (2006) 0.90
Quantification of circulating DNA: in the preparation lies the rub. Clin Chem (2001) 0.90
Filling-in percepts produced by luminance modulation. Vision Res (1996) 0.90
Levels of circulating cell-free serum DNA in benign and malignant breast lesions. Int J Biol Markers (2007) 0.90
Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma--case report. Prenat Diagn (2004) 0.89